Open AccessLONG-TERM METABOLIC CONSEQUENCES OF SWITCHING FROM PROTEASE INHIBITORS TO EFAVIRENZ IN THERAPY FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH LIPOATROPHY
Author(s) -
AUTHOR_ID
Publication year - 2002
Publication title -
infectious diseases in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.145
H-Index - 21
eISSN - 1536-9943
pISSN - 1056-9103
DOI - 10.1097/00019048-200205000-00057
Subject(s) - efavirenz , medicine , lipoatrophy , human immunodeficiency virus (hiv) , virology , antiretroviral therapy , protease , pharmacology , viral load , enzyme , biology , biochemistry